Product
소개
CyteFinder® II HT Instrument
희소 세포 검출을 위한 면역형광 이미징 (Immunofluorescence Imaging) 시스템
• 80개 슬라이드(slide) 자동 분석 시스템
• 희소 세포 검출 및 분석에 최적화된 고속 시스템
• 머신 러닝 알고리즘을 이용한 후보 세포(candidate cell) 검출 및 순위 지정
• 전체 슬라이드 이미징(Whole-slide imaging)
• 디지털 병리학 연구를 위한 조직 분석 옵션(Tissue option for digital pathology)
• 단일 스캔으로 최대 7개 형광 채널을 이용한 바이오마커 7개 동시 검출
CyteFinder II HT Instrument
80개 슬라이드(slide) 자동 분석 모델
Representative circulating tumor cell imaged using a CyteFinder Instrument Intestine tissue image viewed in RareCyte software
EpCAM (red) / PD-L1 (green) / Nuclei (orange) / CD45 (blue)
어플리케이션
[ RareCyte 사 CTC 분석 문헌 ]
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Circulating tumor cells (CTCs) are prognostic in patients with breast cancer. Several technical platforms exist for their enumeration and characterization. Comparative studies between these platforms are scarce. The RareCyte CTC detection is theoretically more sensitive than the established CellSearch platform, which identifies only CTCs that express EpCAM and cytokeratin. This study prospectively compares CTC enumeration in patients with breast cancer in a paired analysis using these two platforms. It investigates survival outcomes in groups defined by a CTC count threshold.
Dirix L, Buys A, Oeyen S. et al.
Breast Cancer Res Treat. 2022.
동영상
관련자료